Assets in USD of ArriVent BioPharma, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit: us-gaap: USD
Description: Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.
Summary: ArriVent BioPharma, Inc. quarterly Assets history and growth rate from Q4 2023 to Q3 2025.
ArriVent BioPharma, Inc. Assets for the quarter ending September 30, 2025 was $327M, a 11.6% increase year-over-year.

Assets, Quarterly (USD)

Assets, YoY Quarterly Growth (%)

ArriVent BioPharma, Inc. Quarterly Assets (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q3 2025	$327M	+$33.8M	+11.6%	Sep 30, 2025	10-Q	2025-11-10
Q2 2025	$270M	-$39.3M	-12.7%	Jun 30, 2025	10-Q	2025-08-11
Q1 2025	$215M	-$112M	-34.3%	Mar 31, 2025	10-Q	2025-05-12
Q4 2024	$275M	+$112M	+68.6%	Dec 31, 2024	10-Q	2025-11-10
Q3 2024	$293M			Sep 30, 2024	10-Q	2024-11-14
Q2 2024	$309M			Jun 30, 2024	10-Q	2024-08-14
Q1 2024	$328M			Mar 31, 2024	10-Q	2024-05-08
Q4 2023	$163M			Dec 31, 2023	10-K	2025-03-03

* An asterisk sign (*) next to the value indicates that the value is likely invalid.